Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 14:2020:6782872.
doi: 10.1155/2020/6782872. eCollection 2020.

The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases

Fangzhou Jiao  1 , Zuojiong Gong  1
Affiliations
Review

The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases

Fangzhou Jiao et al. Oxid Med Cell Longev. .

Abstract

Sirtuins are the class III of histone deacetylases whose deacetylate of histones is dependent on nicotinamide adenine dinucleotide (NAD+). Among seven sirtuins, SIRT1 plays a critical role in modulating a wide range of physiological processes, including apoptosis, DNA repair, inflammatory response, metabolism, cancer, and stress. Neuroinflammation is associated with many neurological diseases, including ischemic stroke, bacterial infections, traumatic brain injury, Alzheimer's disease (AD), and Parkinson's disease (PD). Recently, numerous studies indicate the protective effects of SIRT1 in neuroinflammation-related diseases. Here, we review the latest progress regarding the anti-inflammatory and neuroprotective effects of SIRT1. First, we introduce the structure, catalytic mechanism, and functions of SIRT1. Next, we discuss the molecular mechanisms of SIRT1 in the regulation of neuroinflammation. Finally, we analyze the mechanisms and effects of SIRT1 in several common neuroinflammation-associated diseases, such as cerebral ischemia, traumatic brain injury, spinal cord injury, AD, and PD. Taken together, this information implies that SIRT1 may serve as a promising therapeutic target for the treatment of neuroinflammation-associated disorders.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Xanthos D. N., Sandkühler J. Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity. Nature Reviews Neuroscience. 2014;15(1):43–53. doi: 10.1038/nrn3617. - DOI - PubMed
    1. Meneses G., Cárdenas G., Espinosa A., et al. Sepsis: developing new alternatives to reduce neuroinflammation and attenuate brain injury. Annals New York Academy Sciences. 2019;1437(1):43–56. doi: 10.1111/nyas.13985. - DOI - PubMed
    1. DiSabato D. J., Quan N., Godbout J. P. Neuroinflammation: the devil is in the details. Journal Neurochemistry. 2016;139(Supplement 2):136–153. doi: 10.1111/jnc.13607. - DOI - PMC - PubMed
    1. Ladak A. A., Enam S. A., Ibrahim M. T. A review of the molecular mechanisms of traumatic brain injury. World Neurosurgery. 2019;131:126–132. doi: 10.1016/j.wneu.2019.07.039. - DOI - PubMed
    1. Schwartz M., Deczkowska A. Neurological disease as a failure of brain-immune crosstalk: the multiple faces of neuroinflammation. Trends Immunology. 2016;37(10):668–679. doi: 10.1016/j.it.2016.08.001. - DOI - PubMed

MeSH terms